Live feed
Filing
SC 13G/A
SC 13G/A0001137774-16-000149·EPIRUS Biopharmaceuticals, Inc.
Schedule 13G ownership disclosure
EPIRUS BIOPHARMACEUTICALS INC
Security class unavailable · CUSIP: 29428P107
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,598,001
- Percent of class
- Unavailable
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001137774-16-000149
- Form type
- SC 13G/A
- Filer
- EPIRUS Biopharmaceuticals, Inc.
- CIK
- CIK 1135906
- Filed
- Jan 28, 2016
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership